HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.

AbstractOBJECTIVE:
To report 3-year outcomes of patients who participated in a randomized trial evaluating 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone compared with focal/grid photocoagulation for treatment of diabetic macular edema.
METHODS:
Eyes with diabetic macular edema and visual acuities of 20/40 to 20/320 were randomly assigned to focal/grid photocoagulation or 1 mg or 4 mg of triamcinolone. At the conclusion of the trial, 3-year follow-up data were available in 306 eyes.
RESULTS:
Between 2 years (time of the primary outcome) and 3 years, more eyes improved than worsened in all 3 treatment groups. Change in visual acuity letter score from baseline to 3 years was +5 in the laser group and 0 in each triamcinolone group. The cumulative probability of cataract surgery by 3 years was 31%, 46%, and 83% in the laser and 1-mg and 4-mg triamcinolone groups, respectively. Intraocular pressure increased by more than 10 mm Hg at any visit in 4%, 18%, and 33% of eyes, respectively.
CONCLUSIONS:
Results in a subset of randomized subjects who completed the 3-year follow-up are consistent with previously published 2-year results and do not indicate a long-term benefit of intravitreal triamcinolone relative to focal/grid photocoagulation in patients with diabetic macular edema similar to those studied in this clinical trial. Most eyes receiving 4 mg of triamcinolone as given in this study are likely to require cataract surgery.
TRIAL REGISTRATION:
clinicaltrials.gov Identifier: NCT00367133.
AuthorsDiabetic Retinopathy Clinical Research Network (DRCR.net), Roy W Beck, Allison R Edwards, Lloyd P Aiello, Neil M Bressler, Frederick Ferris, Adam R Glassman, Elizabeth Hartnett, Michael S Ip, Judy E Kim, Craig Kollman
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 127 Issue 3 Pg. 245-51 (Mar 2009) ISSN: 1538-3601 [Electronic] United States
PMID19273785 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural)
Chemical References
  • Glucocorticoids
  • Preservatives, Pharmaceutical
  • Triamcinolone Acetonide
Topics
  • Aged
  • Cataract (chemically induced)
  • Cataract Extraction (statistics & numerical data)
  • Diabetic Retinopathy (drug therapy, surgery, therapy)
  • Female
  • Follow-Up Studies
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Injections
  • Intraocular Pressure
  • Laser Coagulation (methods)
  • Macular Edema (drug therapy, surgery, therapy)
  • Male
  • Middle Aged
  • Preservatives, Pharmaceutical
  • Retina (drug effects, pathology)
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Triamcinolone Acetonide (adverse effects, therapeutic use)
  • Visual Acuity
  • Vitreous Body

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: